Vitamins & Supplements

Bacillopeptidase F: Its Impact on Metabolic Syndrome Disorder

By Erik Goldman

Metabolic disorders, especially overweight and obesity, diabetes, and dyslipidemia are some of the most common illnesses all over the world, carrying a high burden of cardiovascular morbidity and mortality. In this free webinar, renowned integrative physician Fred Pescatore, MD, will share the science on a soy-derived fibrinolytic enzyme called Bacillopeptidase F, which is shown to […]

Fine-Tuning the Digestive Symphony

By Russell Jaffe, MD, Contributing Writer

I like to think of digestion as a magnificent symphony in which a diverse array of organs, bacteria, and biochemicals work in concert to transform the foods we eat into the nutrients and energy we need. If any instrument is out of tune, the music suffers. This notion of the digestive system as an orchestra […]

Nicotinamide Riboside Combo Formula Improves Hepatic Profiles in NAFLD

By August West, Contributing Writer

Daily supplementation with a fixed dose combination of nicotinamide riboside, L-carnitine, L-serine, and N-acetyl cysteine significantly reduced liver fat, quelled oxidative stress, and improved liver enzyme profiles in a cohort of 31 patients with non-alcoholic fatty liver disease (NAFLD). Defined as hepatic fat accumulation of 5% or more, unrelated to alcohol consumption or other liver […]

Glycocalyx Restoration is Key for Lowering CVD Risk

By Erik Goldman

Repair of the endothelial glycocalyx is a vital element in the restoration of cardiovascular health, according to Mark Houston, MD, director of the Hypertension Institute at Saint Thomas West Hospital, Nashville. The endothelial glycocalyx (EGX) —literally “sugar coating” in Greek—is a very thin gel-like layer that lines the luminal surface of the blood vessels. It […]

FDA & AMA Team Up to “CMEar” Dietary Supplements

By Erik Goldman, Editor

If you want to understand why so many Americans distrust the Food and Drug Administration and the medical mainstream, look no further than the FDA’s new online medical education program on dietary supplements. Produced in collaboration with the American Medical Association, this three-part continuing medical education (CME) course—and I use that term loosely—is part of […]

Leveraging the Power of Probiotics To Treat Liver Disease

By Erik Goldman

Probiotics could be an important piece of the therapeutic puzzle for people with hepatic cirrhosis and other forms of progressive liver disease. Research from around the world is shedding light on the so-called “gut-liver axis” and the ways in which the gut microbiome affects liver function, both negatively and positively.  This work opens up promising […]

Non-Rx Female Hormone Support Made Simple

By Erik Goldman

Bioidentical Hormone Replacement Therapy (BHRT) has improved the lives of millions of perimenopausal and menopausal women. But let’s face it: fulfilling BHRT prescriptions at compounding pharmacies is a hassle for patients and practitioners alike. It is also a lost revenue stream for practitioners. There has never been a comprehensive non-prescription hormone balancing system that delivers […]

FDA Leaves NAC In Regulatory Limbo

By Erik Goldman

After nearly two years of contention, the Food and Drug Administration has signaled that it will not ban the use of N-acetyl-cysteine (NAC) in dietary supplements. At the same time the agency refuses to reverse its steadfast position that NAC is a pharmaceutical ingredient which, by definition, excludes it from the supplement category. This leaves […]

Eyeing Practice Evolution, Fullscript Acquires Emerson

By Erik Goldman

Fullscript CEO Kyle Braatz is on what he calls a “forever” mission: to establish a comprehensive technological infrastructure for the transformation of integrative and functional medicine into simply “medicine.” With the acquisition of its main competitor, Emerson Ecologics, Fullscript has taken a major step toward fulfillment of that mission. The deal, announced in mid-March, will […]